A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group.

P, Glue; R, Rouzier-Panis; C, Raffanel; R, Sabo; SK, Gupta; M, Salfi; S, Jacobs; RP, Clement

doi:10.1053/jhep.2000.16661

Public

A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group.

Shared by NobleBlocks on Sep 1, 2000 • 12:00 AM UTC

Authors:

Glue P

Rouzier-Panis R

Raffanel C

Abstract

The objectives of this study were to assess the safety, pharmacokinetics, and efficacy of pegylated interferon alfa-2b (PEG-Intron) plus ribavirin in patients with chronic hepatitis C. A total of 72 patients (35 men/37 women, age range 20-68 years) with clinically compensated chronic hepatitis C vir...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!